[Factors associated with the type of mask used during nocturnal NIV in patients with neuromuscular disorders]

Rev Mal Respir. 2020 Feb;37(2):99-104. doi: 10.1016/j.rmr.2019.11.646. Epub 2020 Jan 22.
[Article in French]

Abstract

In subjects with neuromuscular diseases (NMD), the choice of facemask is essential for successful long-term noninvasive ventilation (NIV). While nasal masks usually represent the first line of treatment, almost a third of our subjects with NMD use an oro-nasal interface. Factors associated with the choice of mask remain poorly understood. We provide an original analysis of a previous prospective, multi-centric, Franco-Belgian survey investigating the factors associated with the type of nocturnal mask used in 116 adult NMD subjects treated with NIV. In these patients oro-nasal mask use was more often associated with non-Duchenne muscular dystrophy, older subjects, higher body mass index, better upper limb autonomy allowing independent mask removal and shorter periods of ventilation. Controlled prospective studies are needed to compare the efficacy and tolerance of different interfaces in this specific population.

Keywords: Maladies neuromusculaires; Masque nasal; Masque oro-nasal; Nasal mask; Neuromuscular diseases; Noninvasive ventilation; Oronasal mask; Tolerance; Tolérance; Ventilation non invasive.

MeSH terms

  • Adult
  • Age Factors
  • Age of Onset
  • Body Mass Index
  • Choice Behavior / physiology*
  • Equipment Design
  • Female
  • Humans
  • Male
  • Masks* / statistics & numerical data
  • Middle Aged
  • Neuromuscular Diseases / complications
  • Neuromuscular Diseases / epidemiology
  • Neuromuscular Diseases / therapy*
  • Noninvasive Ventilation / instrumentation*
  • Noninvasive Ventilation / statistics & numerical data
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Patient Compliance / psychology
  • Patient Compliance / statistics & numerical data
  • Respiratory Insufficiency / complications
  • Respiratory Insufficiency / epidemiology
  • Respiratory Insufficiency / therapy*
  • Socioeconomic Factors